Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Tofacitinib Citrate, a Janus kinase (JAK) inhibitor, has revolutionized the treatment landscape for several inflammatory and autoimmune diseases. Its therapeutic efficacy stems from a precise molecular structure, achieved through sophisticated multi-step chemical synthesis. Understanding these synthesis pathways provides valuable insight into the critical role played by various chemical intermediates.
The synthesis of Tofacitinib Citrate typically involves building the core pyrrolo[2,3-d]pyrimidine ring structure, which is then elaborated with specific functional groups and side chains. A key intermediate in this process is N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine, designated by CAS No. 923036-30-0. This compound serves as a crucial precursor, embedding a significant portion of the final Tofacitinib molecule's architecture.
The meticulous control over the stereochemistry and purity of intermediates like CAS 923036-30-0 is paramount. Any deviation can lead to the formation of unwanted isomers or impurities, which can impact the drug's safety and efficacy. Therefore, pharmaceutical manufacturers place a high premium on sourcing these intermediates from reliable suppliers who can guarantee consistent quality. The availability of this specific Tofacitinib Citrate intermediate in a pure powder form is essential for its integration into the synthesis workflow.
The chemical industry, through companies such as NINGBO INNO PHARMCHEM CO., LTD., plays a vital role in making these complex intermediates accessible. By focusing on the efficient and high-quality synthesis of compounds like N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine, they enable pharmaceutical companies to conduct their research and manufacturing operations more effectively.
Further steps in the synthesis often involve coupling reactions and functional group transformations to arrive at the final Tofacitinib Citrate salt. The efficiency of these subsequent steps is often influenced by the quality of the starting intermediates. Therefore, a robust understanding of the entire synthesis pathway, from the initial building blocks to the final API, is crucial for successful drug development and manufacturing.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
